FDA-Drug2015-12-23Class III
Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98
Teva Pharmaceutical Industries
Hazard
Labeling: Incorrect or Missing Lot AND/OR Exp Date.
Sold states
Nationwide
Affected count
3536 bottles
Manufactured in
20 Kiryat HaMada Street,, Har Hozvim, Jerusalem, N/A, Israel
Products
Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0521-2016Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief